Enzyme Kinetics for Clinically Relevant CYP Inhibition

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|6|3|241-257

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.6, Iss.3, 2005-06, pp. : 241-257

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Are the Pleiotropic Effects of Telmisartan Clinically Relevant?

By  

Current Pharmaceutical Design, Vol. 15, Iss. 24, 2009-08 ,pp. : 2815-2832

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of Procarcinogen Activating Enzyme CYP1A2 Activity and Free Radical Formation by Caffeic Acid and its Amide Analogues

By  

Drug Metabolism Letters, Vol. 10, Iss. 3, 2016-09 ,pp. : 187-194

Bentham Science Publishers

Access to resources Recommend Favorite

Enzyme Inhibition

By  

Current Bioactive Compounds, Vol. 3, Iss. 4, 2007-12 ,pp. : 310-311

Bentham Science Publishers

Access to resources Recommend Favorite

A Literature Review of Enzyme Kinetic Parameters for CYP3A4-Mediated Metabolic Reactions of 113 Drugs in Human Liver Microsomes: Structure- Kinetics Relationship Assessment

By  

Current Drug Metabolism, Vol. 7, Iss. 3, 2006-04 ,pp. : 231-249

Bentham Science Publishers

Access to resources Recommend Favorite

Enzymatic and Inhibition Mechanism of Human Aromatase (CYP19A1) Enzyme. A Computational Perspective from QM/MM and Classical Molecular Dynamics Simulations

By  

Mini Reviews in Medicinal Chemistry, Vol. 16, Iss. 14, 2016-09 ,pp. : 1112-1124

Bentham Science Publishers

Access to resources Recommend Favorite